Natco Pharma today said its consolidated net profit rose by 13% to Rs 13.72 crore for the quarter ended December 31, 2010, from the same period last fiscal.
The company had posted a consolidated net profit of Rs 12.14 crore in the corresponding period previous fiscal, Natco Pharma said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company rose to Rs 118.34 crore for the third quarter this fiscal from Rs 117.06 crore for the same quarter year ago.
In another filing to the BSE, Natco pharma said its board of directors in a meeting held today have recommended payment of interim dividend of Rs 2 per equity shares of Rs 10 each for the year 2010- 2011.
Shares of Natco Pharma today closed at Rs 271.10 on the BSE, up 1.02% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app